Johnson & Johnson (JNJ) is a consumer/health company with outstanding cash-flow and a very consistent dividend. Its combination of operations makes it a very secure investment with some interesting growth potential. Furthermore, given the recent emphasis on hygiene, I expect J&J's products to get a boost in sales post COVID.

JNJ has been around since 1887 and has three main lines of business; Consumer, Pharmaceutical and Medical Devices. Over the past few years, JNJ has posted moderate but consistent revenue growth. The same can be said of the dividend, which has kept a steady payout growth of 6.32% over the past 5 years. Not surprising considering JNJ is a dividend king.

READ FULL ARTICLE HERE